The Valley Desk

NCT00387920 · Interventional trial

Sunitinib in Treating Young Patients With Refractory Solid Tumors

Overall registry status Completed

Phase 1

Conditions Central Nervous System Metastases, Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Recurrent Childhood Central Nervous System Embryonal Tumor, Unspecified Childhood Solid Tumor, Protocol Specific

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov